Moffitt Cancer Center
Tampa, Florida, 33612, United States
NCT Number: NCT04914000
This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.
Looking for future studies?
Notify MeHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Self-help booklet targeted by cancer type to increase smoking cessation motivation
Time frame: Baseline
Number of participants who consent to participate in the study
Time frame: 1-week post-treatment
Number of participants who complete 1-week follow-up assessments
Time frame: 1-month post-treatment
Number of participants who complete 1-month follow-up assessments
Time frame: 1-week post-treatment
Number of study participants who read the booklet
Time frame: 1-month post-treatment
Number of study participants who read the booklet
Time frame: 1-month post-treatment
Treatment satisfaction measured with 8 items adapted from the Client Satisfaction Questionnaire, values between 8 and 32, with higher scores mean a better outcome.
Time frame: Baseline, 1-week post-treatment, 1-month post-treatment
Changes in motivation to quit smoking will be assessed using the Contemplation Ladder. This is a validated measure for the assessment of readiness to quit smoking on a scale from 0 to 10. Higher scores indicate greater motivation to quit smoking.
Time frame: Baseline, 1-week post-treatment, 1-month post-treatment
Changes in motivation to quit smoking will be assessed using the short form of the smoking abstinence-related motivational engagement (ARME), which is a valid and reliable measure of cessation motivation that includes 5 items related to the smokers' daily experience with scores ranging from 5 to 35. Higher scores indicate greater motivation to quit smoking.
Time frame: Baseline, at 1 week and 1 month post treatment
Changes in motivation to quit smoking will be assessed using the Stages of Change algorithm (SOC). This is a widely used measure for the assessment of readiness to quit smoking.
Time frame: 1-month post-treatment
A personal code will be able to track the number of participants who visited the study website where participants will find existing smoking cessation resources. This will be considered a behavioral indicator of motivation to quit smoking.
Time frame: At 1 Week Post Treatment
Participants will be asked if they have contacted the tobacco treatment specialist or if they would like us to make a referral for them. This will be considered a behavioral indicator of motivation to quit smoking.
Time frame: At 1 Month Post Treatment
Participants will be asked if they have contacted the tobacco treatment specialist or if they would like us to make a referral for them. This will be considered a behavioral indicator of motivation to quit smoking.
Time frame: At 1 Week Post Treatment
Number of participants that had a quit attempt that lasted at least 24 hours (at the 1-week assessment)
Time frame: At 1 Month Post Treatment
Number of participants that had a quit attempt that lasted at least 24 hours
Time frame: At 1 Month Post Treatment
Number of times participants quit smoking in the last 30 days (at the 1-month assessment).
Time frame: 1-week post-treatment
Smoking abstinence will be determined by a self-report of not smoking in the last 7 days
Time frame: 1-month post-treatment
Smoking abstinence will be determined by a self-report of not smoking in the last 30 days
H. Lee Moffitt Cancer Center and Research Institute
Other
Motivating a Spectrum of Cancer Patients to Quit Smoking: Intervention Development and Feasibility
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04738643
Behavior, Cancer
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04737031
Behavior, Cancer
Lancaster, Pennsylvania, United States
View Trial DetailsNCT03600038
Behavior, Cancer
Seattle, Washington, United States
View Trial DetailsNCT01673243
Anemia, Anemia, Hemolytic
Memphis, Tennessee, United States
View Trial Details